AMNEAL PHARMACEUTICALS, INC. AMRX

19.77 (0.04) (0.20%) as of 25 Sep
Market cap
$6.3B
P/E
39.5×
Growth Flags show if company had growth for consecutive years
Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
P/E ratio
0.00 0.00 0.00 0.00 8.61 69.22 0.00 0.00 0.00 54.78
P/S ratio
0.96 0.96 1.04 0.39 0.34 0.34 0.14 0.44 0.88 1.31
P/FCF ratio
11.38 11.38 9.65 0.00 2.15 1.61 6.76 3.81 11.12 17.34
P/Operating CF
39.76 39.76 6.63 (12.51) 6.36 11.28 (13.67) 7.75 20.72 30.30
P/B ratio
18.03 18.03 1.92 1.84 1.95 1.94 1.73 52.64 0.00 0.00
Price to Tangible BV
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EV/Sales
1.56 1.56 2.52 1.95 1.61 1.53 1.36 1.50 1.74 2.06
EV/EBITDA
4.39 4.39 31.30 2,229.97 9.55 8.11 19.53 8.07 9.47 9.70
EV/Operating CF
7.95 7.95 16.76 1,862.71 8.45 13.25 46.16 10.40 16.51 18.26
EV/FCF
18.63 18.63 23.50 (33.18) 10.24 7.21 63.75 13.01 22.13 27.27
Quick Ratio
1.37 1.50 1.27 1.38 1.46 1.36 1.03 0.84 0.79 1.37
Current Ratio
1.96 2.60 2.32 2.20 2.29 2.24 1.88 1.63 1.41 2.17
Net Debt/EBITDA
2.03 4.76 18.45 1,783.00 7.54 6.30 17.46 5.71 4.71 3.62
Debt/Assets
45.60% 110.62% 61.83% 73.43% 71.79% 69.77% 71.63% 76.04% 72.62% 71.41%
Debt/Equity
1.33 (3.95) 3.00 7.76 8.34 7.49 14.79 131.96 (23.22) (36.83)
Asset Turnover
0.54 0.65 0.58 0.41 0.52 0.53 0.57 0.66 0.80 0.84
Operating CF/Net income
0.00 0.00 (11.96) 0.00 4.16 22.76 (0.50) (4.11) (2.52) 4.72
Capex/Depreciation
(3.45) (2.26) (0.47) (0.39) (0.27) (0.20) (0.36) (0.29) (0.28) (0.46)
Interest Coverage
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
ROE
0.00% 0.00% (8.03%) (58.23%) 26.33% 2.98% (47.19%) (82.35%) 261.19% (79.69%)
ROA
0.00% 0.00% (0.73%) (9.03%) 2.37% 0.27% (3.36%) (2.31%) (3.35%) 2.01%
ROIC
13.96% 14.86% (0.36%) (5.39%) 1.98% 3.34% (2.07%) 4.99% 6.73% 10.97%
Return on Tangible Assets
0.00% 0.00% (1.64%) (31.81%) 6.73% 0.78% (11.52%) (8.58%) (13.24%) 4.89%
Average Days of Receivables
93.52 129.80 105.86 136.04 117.29 115.72 122.47 93.73 101.40 108.29
Research and Development Expense of Revenue
17.58% 16.58% 11.68% 11.56% 9.03% 9.64% 8.85% 6.85% 6.83% 6.17%
Selling, General and Administrative Expense of Revenue
11.66% 10.55% 13.70% 17.81% 16.40% 17.46% 18.07% 17.95% 17.05% 17.45%
Intangible Assets out of Total Assets
0.45 0.05 0.48 0.49 0.46 0.45 0.45 0.43 0.38 0.32
Share Based Compensation of Revenue
0.00% 0.00% 10.08% 1.33% 1.04% 1.36% 1.44% 1.12% 0.99% 1.06%
Graham Net Nets
(0.54) (0.54) (1.26) (3.31) (3.13) (2.88) (6.92) (1.97) (0.83) (0.47)
Graham Number
0.00 0.00 0.00 0.00 5.29 1.96 0.00 0.00 1.74 0.00
Earnings Yield
(43.44%) (43.44%) (45.58%) (57.26%) 11.61% 1.44% (40.76%) (7.95%) (4.80%) 1.83%
Free Cash Flow Yield
8.79% 8.79% 10.37% (15.03%) 46.42% 62.30% 14.80% 26.24% 8.99% 5.77%
Revenue per Share
14.34 13.97 13.07 12.31 13.51 14.06 14.66 13.59 9.04 9.63
Operating CF per Share
1.62 3.16 1.97 0.01 2.57 1.62 0.43 1.96 0.96 1.09
Capex per Share
(1.75) (1.54) (0.56) (0.74) (0.45) (0.32) (0.60) (0.39) (0.24) (0.36)
Free Cash Flow per Share
(0.13) 1.62 1.40 (0.72) 2.12 1.30 (0.17) 1.57 0.71 0.73
Cash per Share
2.54 1.05 1.72 1.16 2.35 1.72 0.23 0.56 0.38 0.99
Shareholders Equity per Share
8.79 (5.08) 7.04 2.63 2.34 2.46 1.22 0.11 (0.35) (0.23)
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
8.79 (5.08) 7.04 2.63 2.34 2.46 1.22 0.11 (0.35) (0.23)
Free Cash Flow
(9.55) 119.92 178.49 (95.73) 312.82 194.18 (25.49) 276.39 220.11 227.73
Working Capital
309.82 475.05 732.79 659.80 874.64 842.87 659.02 531.27 458.04 1,029.55
Capital Expenditures
(124.61) (114.27) (71.74) (97.43) (66.19) (47.64) (90.59) (69.19) (74.99) (112.26)
Net Current Asset Value
(567.90) (945.54) (2,169.73) (2,108.89) (2,109.56) (2,052.58) (2,203.54) (2,074.69) (2,023.15) (1,838.43)
EV/EBIT
4.88 4.88 0.00 0.00 35.14 20.99 0.00 17.59 19.54 15.76
Capex to Sales
0.12 0.11 0.04 0.06 0.03 0.02 0.04 0.03 0.03 0.04
Net Profit Margin
0.00% 0.00% (1.26%) (22.25%) 4.57% 0.51% (5.88%) (3.51%) (4.18%) 2.39%
Price to Operating Income
2.98 2.98 0.00 0.00 7.39 4.67 0.00 5.15 9.81 10.02
Other line items
Depreciation/Fixed assets
0.15 0.10 0.28 0.52 0.51 0.47 0.53 0.54 0.62 0.56
Cash ROIC
(7.23%) (21.28%) (7.72%) (14.92%) (2.77%) (8.08%) (13.76%) (3.70%) (5.09%) (3.59%)
Accounts Receivable Turnover
3.48 3.29 3.91 2.99 3.20 3.21 3.15 3.53 4.02 3.61
Accounts Payable Turnover
7.30 4.00 2.67 2.49 2.44 2.33 2.68 2.93 2.79 2.55
Inventory Turnover
2.80 2.21 2.55 3.04 3.13 2.70 2.80 2.83 2.97 3.13
Average Days of Payables
51.14 140.09 198.37 145.46 163.72 144.75 137.60 124.06 151.36 145.83
Days of Inventory on Hand
152.00 204.29 176.30 109.23 131.28 134.84 135.70 134.90 126.05 116.14
Average Receivables
292.67 314.23 424.95 544.24 623.23 652.03 703.03 678.49 695.45 835.91
Average Payables
57.64 126.87 354.61 510.96 559.68 568.61 531.77 536.43 635.06 748.38
Average Inventory
150.41 229.63 370.63 419.14 435.86 490.02 510.06 556.06 596.92 609.38
Average Assets
1,872.75 1,582.45 2,847.31 4,009.31 3,835.96 3,972.85 3,869.50 3,635.96 3,487.01 3,589.86
Average Common Equity
843.19 124.20 260.39 621.58 345.86 355.95 275.48 102.00 (44.75) (90.42)

Fold the line items

Columns are period end dates